Neurology
Found 72 results
Filters: Keyword is Magnetic Resonance Imaging  [Clear All Filters]
2019
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
Zhang S, Nguyen TD, Rúa SMHurtado, Kaunzner UW, Pandya S, Kovanlikaya I, Spincemaille P, Wang Y, Gauthier SA.  2019.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.. AJNR Am J Neuroradiol. 40(6):987-993.
Merkler AE, Alakbarli J, Gialdini G, Navi BB, Murthy SB, Goyal P, Kim J, Devereux RB, Safford MM, Iadecola C et al..  2019.  Short-Term Risk of Ischemic Stroke After Detection of Left Ventricular Thrombus on Cardiac Magnetic Resonance Imaging.. J Stroke Cerebrovasc Dis. 28(4):1027-1031.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.
2018
Chen MLin, Gupta A, Chatterjee A, Khazanova D, Dou E, Patel H, Gialdini G, Merkler AE, Navi BB, Kamel H.  2018.  Association Between Unruptured Intracranial Aneurysms and Downstream Stroke.. Stroke. 49(9):2029-2033.
Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, Matthews DC, Vallabhajosula S, de Leon MJ, Isaacson RS et al..  2018.  Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.. BMJ Open. 8(11):e023664.
Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA.  2018.  Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.. Neuroimage Clin. 19:417-424.
Yao Y, Nguyen TD, Pandya S, Zhang Y, S Rúa H, Kovanlikaya I, Kuceyeski A, Liu Z, Wang Y, Gauthier SA.  2018.  Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.. AJNR Am J Neuroradiol. 39(2):303-310.
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Nguyen TD, Zhang S, Gupta A, Zhao Y, Gauthier SA, Wang Y.  2018.  Fast and Robust Unsupervised Identification of MS Lesion Change Using the Statistical Detection of Changes Algorithm.. AJNR Am J Neuroradiol. 39(5):830-833.
Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD.  2018.  The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review.. Clin Imaging. 47:80-89.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.  2018.  Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
Deh K, Ponath GD, Molvi Z, Parel G-CT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A et al..  2018.  Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.. J Magn Reson Imaging. 48(5):1281-1287.
Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S et al..  2018.  Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. Neurology. 90(20):e1789-e1798.
Chiang GC, Hu J, Morris E, Wang Y, Gauthier SA.  2018.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.. AJNR Am J Neuroradiol. 39(3):467-472.
Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, J Mann J, Oquendo MA, Parsey RV et al..  2018.  Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.. Hum Brain Mapp. 39(2):1043-1055.
2017
Kaunzner UW, Salamon E, Pentsova E, Rosenblum M, Karimi S, Nealon N, Lavi E, Jamieson DG.  2017.  An Acute Disseminated Encephalomyelitis-Like Illness in the Elderly: Neuroimaging and Neuropathology Findings.. J Neuroimaging. 27(3):306-311.
Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al..  2017.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.
Al-Kawaz M, Monohan E, Morris E, Perumal JS, Nealon N, Vartanian T, Gauthier SA.  2017.  Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.. J Neuroimaging. 27(3):333-338.
Eskreis-Winkler S, Zhou D, Liu T, Gupta A, Gauthier SA, Wang Y, Spincemaille P.  2017.  On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.. Magn Reson Imaging. 35:154-159.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al..  2017.  Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.. N Engl J Med. 376(3):221-234.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.